Spero Therapeutics (SPRO) Share-based Compensation Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | -19.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.93% |
| Dec 31, 2025 | -26.12% |
| Sep 30, 2025 | -20.76% |
| Jun 30, 2025 | -18.46% |
| Mar 31, 2025 | -21.39% |
| Dec 31, 2024 | -19.93% |
| Sep 30, 2024 | -2.58% |
| Jun 30, 2024 | -0.78% |
| Mar 31, 2024 | 0.23% |
| Dec 31, 2023 | 13.52% |
| Sep 30, 2023 | 16.75% |
| Jun 30, 2023 | 15.22% |
| Mar 31, 2023 | 25.04% |
| Dec 31, 2022 | 39.04% |
| Sep 30, 2022 | 29.00% |
| Jun 30, 2022 | 12.18% |
| Mar 31, 2022 | 50.85% |
| Dec 31, 2021 | 56.15% |
| Sep 30, 2021 | 48.96% |
| Jun 30, 2021 | 48.46% |
| Mar 31, 2021 | 48.46% |
| Dec 31, 2020 | 54.10% |
| Sep 30, 2020 | 8.80% |
| Jun 30, 2020 | 171.00% |
| Mar 31, 2020 | 161.60% |
| Dec 31, 2019 | 145.22% |
| Sep 30, 2019 | 153.81% |